Is a complete CTKB research report available?

No complete published report is available for Cytek Biosciences, Inc. (CTKB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Cytek Biosciences, Inc. (CTKB)

NASDAQ: CTKB · USD

$4.31

-0.07 (-1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CTKB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	556.6M
Revenue (ttm)	204.2M
Net income (ttm)	-74M
EPS (ttm)	-$0.58
Shares out	129.1M
Volume	525,927
Beta	1.17
Price target	$5.69	+32.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 204.2M
Net income (ttm): -74M
EPS (ttm): -$0.58
Market cap: 556.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CTKB indicators

Market & fundamental data

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001831915
Company name	Cytek Biosciences, Inc.
Country	United States
Country code	US
Cusip	23285D109
Employees	678
Employees Change	-24%
Employees Change Percent	-3.42
Enterprise value	$321.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.96
Industry PE Fwd	19.8
IPO Date	2021-07-23
Isin	US23285D1090
Last refreshed	2026-07-31
Market cap	$556.6M
Market cap category	Small-Cap
Price	$4.31
Price currency	USD
Rev Per Employee	301,137.17x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	3826
Symbol	CTKB
Website	https://cytekbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.3%
EV Sales Forward	1.52x
EV/Sales	1.58x
FCF yield	-2.28%
P/B ratio	1.7x
P/S ratio	2.73x
PS Forward	2.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-21.49%
EBITDA Margin	-15.66%
Gross margin	51.7%
Gross Profit	$105.6M
Gross Profit Growth	-2.49%
Gross Profit Growth Q	5.44%
Gross Profit Growth3 Y	1.2%
Gross Profit Growth5 Y	12.79%
Net Income	$-74M
Net Income Growth Years	0%
Pretax Margin	-17.61%
Profit Margin	-36.25%
Profit Per Employee	$-109,149
ROA	-5.89
Roa5y	-1.96
ROCE	-11.92
ROE	-20.93
Roe5y	-4.18
ROIC	-44.57
Roic5y	-11.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.74%
Cagr3y	-21.73%
Cagr5y	-27.69%
EPS Growth Years	0
Revenue Growth	3.61x
Revenue Growth Q	6.46x
Revenue Growth Quarters	3x
Revenue Growth Years	6x
Revenue Growth3 Y	7.13x
Revenue Growth5 Y	15.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.44
Assets	$449.1M
Cash	$262.2M
Current Assets	$379.3M
Current Liabilities	$80.9M
Debt	$27.5M
Debt Equity	$0.08
Equity	$327.6M
Interest Coverage	-98.59
Liabilities	$121.5M
Long Term Assets	$69.8M
Long Term Liabilities	$40.5M
Net Cash	$234.7M
Net Cash By Market Cap	$42.17
Net Cash Growth	-6%
Net Debt Equity	$-0.72
Tangible Book Value	$295.3M
Tangible Book Value Per Share	$2.29
WACC	10.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.69
Inventory Turnover	2.05
Net Working Capital	$49.8M
Quick ratio	3.94
Working Capital	$298.4M
Working Capital Turnover	$0.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.64%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.72%
200-day SMA	4.57
3Y total return	-52.06%
50-day SMA	4.27
50-day SMA vs 200-day SMA	50under200
5Y total return	-80.23%
All Time High	28.7
All Time High Change	-84.98%
All Time High Date	2021-09-15
All Time Low	2.37
All Time Low Change	81.86%
All Time Low Date	2025-05-23
ATR	0.19
Beta	1.17
Beta1y	0.34
Beta2y	1.2
Ch YTD	-14.65
High	4.38
High52	6.18
High52 Date	2025-11-17
High52ch	-30.26%
Low	4.24
Low52	3.28
Low52 Date	2025-09-25
Low52ch	31.4%
Ma50ch	0.87%
Price vs 200-day SMA	-5.73%
RSI	43.45
RSI Monthly	43.68
RSI Weekly	48.63
Sharpe ratio	0.53x
Sortino ratio	0.92
Total Return	1.64%
Tr YTD	-14.65
Tr1m	-0.69%
Tr1w	-5.48%
Tr3m	-2.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$6.25
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.02
Earnings Revenue Estimate	48,531,760x
Earnings Revenue Estimate Growth	6.42x
Operating Income	$-43.9M
Operating margin	-21.49
Price target	$5.69
Price Target Change	$32.02
Price Target Change Top	$45.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,581,921%
Float Percent	74.79%
Net Borrowing	5,864,000
Shares Insiders	8.47%
Shares Institutions	43.47%
Shares Out	129,142,587
Shares Qo Q	0.42%
Shares Yo Y	-1.64%
Short Float	5.21%
Short Ratio	2.34
Short Shares	3.89

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-35.5M
Adjusted OCF	-30,113,000
Average Volume	774,888.8x
Bv Per Share	2.54
CAPEX	$-5.4M
Ch1m	-0.69
Ch1w	-5.48
Ch1y	19.72
Ch3m	-2.93
Ch3y	-52.06
Ch5y	-80.23
Ch6m	-13.97
Change	-1.6%
Change From Open	-1.6
Close	4.38
Days Gap	0
Depreciation Amortization	7,569,000
Dollar Volume	2,266,745.4
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-43.9M
EBITDA	$-32M
EPS	$-0.58
F Score	3
FCF	$-12.7M
FCF EV Yield	-3.95x
FCF Per Share	$-0.1
Financing CF	2,094,000
Fiscal Year End	December
Founded	1,990
Goodwill	16,689,000
Income Tax	$38.1M
Investing CF	-26,414,000
Ipr	-74.65
Iprfo	-78.56
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	4.52
Ma150ch	-4.69%
Ma20	4.53
Ma20ch	-4.94%
Net CF	-29,634,000
Next Earnings Date	2026-08-05
Open	4.38
Optionable	Yes
Position In Range	50
Ppne	31,112,000
Price Date	2026-07-30
Ptbv Ratio	1.89
Relative Volume	0.68x
Revenue	204,171,000x
SBC By Revenue	11.17x
Share Based Comp	22,816,000
Tax By Revenue	18.64x
Tr6m	-13.97%
Us State	California
Volume	525,927
Z Score	3.14

Cytek Biosciences, Inc. (CTKB)

Coverage state: Market snapshot only — no published research

Generate the first CTKB analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CTKB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CTKB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CTKB

Frequently asked questions